Similar articles

• Lorazepam vs. alprazolam in the treatment of panic disorder.

  Schweizer E, Pohl R, Balon R, Fox I, Rickels K, Yeragani VK. Schweizer E, et al. Pharmacopsychiatry. 1990 Mar;23(2):90-3. doi: 10.1055/s-2007-1014489. Pharmacopsychiatry. 1990. PMID: 2187213 Clinical Trial.
• Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder.

  Westenberg HG, den Boer JA. Westenberg HG, et al. Psychopharmacol Bull. 1989;25(1):119-23. Psychopharmacol Bull. 1989. PMID: 2528158 Clinical Trial. No abstract available.
• The MSH/ACTH analog ORG 2766 in anxiety disorders.

  Den Boer JA, Westenberg HG, De Vries H. Den Boer JA, et al. Peptides. 1992 Jan-Feb;13(1):109-12. doi: 10.1016/0196-9781(92)90147-u. Peptides. 1992. PMID: 1320259 Clinical Trial.
• Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.

  Mavissakalian M. Mavissakalian M. Psychopharmacol Bull. 1989;25(1):27-9. Psychopharmacol Bull. 1989. PMID: 2672069 Review. No abstract available.
• Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of panic disorder: brief review.

  Liebowitz MR. Liebowitz MR. Psychopharmacol Bull. 1989;25(1):17-20. Psychopharmacol Bull. 1989. PMID: 2672068 Review. No abstract available.